Access Cortisol; DxC 500i Clinical Analyzer— 510(k) K242190

Substantially Equivalent

Beckman Coulter, Inc.

FDA 510(k) clearance K242190 for Access Cortisol; DxC 500i Clinical Analyzer, Substantially Equivalent on 2025-03-05. Applicant: Beckman Coulter, Inc..

Clearance details

Applicant
Beckman Coulter, Inc.
Product code
Code CGR
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Brea, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.